Trump Administration Nominates New Surgeon General
Indiana health commissioner Jerome Adams, MD, has been nominated to be the country’s next surgeon general. STAT reported that Vice President Mike Pence appointed Adams to his current role when Pence was still governor. Adams would replace former Surgeon General Vivek Murthy, MD, who was pushed out by the Trump administration in April. Similar to Murthy, Adams has been an advocate for addressing the opioid epidemic.
Investigation Into Patient Assistance Charity
The IRS is investigating whether a patient-assistance charity improperly benefited pharmaceutical companies. The probe is trying to determine whether the charity Good Days returned most of the money pharmaceutical companies donated as payments for their drugs, according to Reuters. Good Days operates a copay assistance program and the IRS claims that in 2011 about 95% of the assistance provided to patients was spent on drugs made by companies that had made donations.
CBO Releases Addendum to Initial Senate Health Bill Report
An addendum from the Congressional Budget Office released Thursday detailed the impact of the Senate health bill on Medicaid over 2 decades. The addendum to the initial analysis was released at the request of Democratic senators who wanted to see an estimate past the 10-year window typically provided. The CBO found that in the first 10 years, Medicaid funding would decrease 26%, and by the end of the second decade, Medicaid spending would be 35% lower.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More